Literature DB >> 7735931

Vacuolating cytotoxin production by Helicobacter pylori isolates from peptic ulcer, atrophic gastritis and gastric carcinoma patients.

H Murakita1, M Hirai, S Ito, T Azuma, T Kato, Y Kohli.   

Abstract

OBJECTIVE: We investigated the production of vacuolating cytotoxin by Helicobacter pylori isolates from patients with peptic ulcer, atrophic gastritis or gastric carcinoma in order to examine the pathophysiological significance of vacuolating cytotoxin in these diseases.
METHODS: H. pylori was isolated from 18 patients (five with peptic ulcers, seven with atrophic gastritis and six with gastric carcinoma). Culture supernatants of H. pylori isolates, concentrated 20-fold, were serially diluted and then analyzed for cytotoxin activity semi-quantitatively using A431 cells as indicator cells. The relative activity of vacuolating cytotoxin was defined according to the maximum dilution.
RESULTS: Cytotoxin production was observed in two out of five, six out of seven and six out of six isolates from peptic ulcer, atrophic gastritis and gastric carcinoma patients, respectively. The mean relative activity was calculated as 0.80, 2.71 and 2.50 in
CONCLUSION: These results suggest that vacuolating cytotoxin-producing H. pylori is strongly associated with both atrophic gastritis and gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7735931

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  2 in total

1.  Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis.

Authors:  S Ito; T Azuma; H Murakita; M Hirai; H Miyaji; Y Ito; Y Ohtaki; Y Yamazaki; M Kuriyama; Y Keida; Y Kohli
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

2.  Cytotoxic isolates of Helicobacter pylori from peptic ulcer diseases decrease K+-dependent ATPase activity in HeLa cells.

Authors:  Awasthi Shanjana; Ayyagari Archana
Journal:  BMC Gastroenterol       Date:  2003-11-06       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.